Beta Bionics Inc expected to post a loss of 45 cents a share - Earnings Preview

Beta Bionics

25/07/2025 21:07

Beta Bionics Inc BBNX.OQ BBNX.O is expected to  report resultson July 29 for the period ending June 30 2025

The Irvine California-based  company is expected to report revenue of $19.684 million, according to the mean estimate from 9 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Beta Bionics Inc is for a loss of 45 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Beta Bionics Inc is $26.00, about 44.5% above its last closing price of $14.43

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.47
-0.48
-0.93
Missed
-95.4
Dec. 31 2025
-0.47
-0.47
-2.72
Missed
-481.8
​
​​
​

This summary was machine generated July 25 at 20:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)